Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
Más filtros

Base de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Transfus Clin Biol ; 18(2): 206-17, 2011 Apr.
Artículo en Francés | MEDLINE | ID: mdl-21466968

RESUMEN

INTRODUCTION: Predonation interview accounts for a major step in transfusion safety. In France, it must be performed by a physician, following a methodical questioning and a standardized questionnaire. Faced with this evolution, the value of a strictly medical expertise has been progressively losing importance. In many countries, blood donor selection is being organized by non medical trained staff (Québec, Switzerland, e.g.). A decree of April 30, 2006 allowed the Établissement français du sang to experiment a predonation interview by an authorized paramedical staff in the form of a two-phase prospective multicenter study over a year. PATIENTS AND METHODS: Phase I "experimental situation": six physician/nurse teams among three blood transfusion centres interviewed 1940 blood-donation candidates, including 253 new donors (13% out of total). Phase 2 "observational study": 3222 blood-donation candidates were interviewed either by a physician or a nurse. RESULTS: In phase I, nurses were able to make a decision without the physician's help in 1921 cases. A total of 1628 candidates were decided capable of donating blood both by physicians and nurses, 174 donors were rejected both by physicians and nurses and 69 were rejected either by physicians or nurses. In phase 2, out of 3222 blood-donation candidates, an average of 12.1% were rejected by nurses and 10% by physicians. CONCLUSION: The study reported a weaker variability among nurses. Results show that nurses were able to perform predonation interviews with high reliability, without additional risk. The reproducibility of their answers in the field of recipient-risk evaluation was better than the physicians.


Asunto(s)
Donantes de Sangre , Seguridad de la Sangre , Selección de Donante/métodos , Entrevistas como Asunto , Enfermeras y Enfermeros , Médicos , Acreditación , Técnicos Medios en Salud , Bancos de Sangre , Donantes de Sangre/psicología , Toma de Decisiones , Selección de Donante/legislación & jurisprudencia , Selección de Donante/estadística & datos numéricos , Estudios de Factibilidad , Estudios de Seguimiento , Humanos , Reproducibilidad de los Resultados , Recursos Humanos
2.
Transfus Clin Biol ; 14(1): 86-9, 2007 May.
Artículo en Francés | MEDLINE | ID: mdl-17521944

RESUMEN

Multiple apheresis makes it possible to obtain at least two labile blood components from a single donor using a cell separator. It can be either multicomponent apheresis leading to the preparation of at least two different blood component types or red blood cell apheresis providing two identical red blood cell concentrates. These techniques available in addition to whole blood donation, are modifying collection strategies in many Etablissements Français du Sang and will contribute to improve stock logistics in the future. In areas with insufficient stock, these procedures will help achieve blood component self-sufficiency. The author first describes the principle underlying different--current or future--techniques as well as their advantages and drawbacks. He finally addresses the potential impact of these processes on the evolution of blood collection and the advantages to be gained.


Asunto(s)
Eliminación de Componentes Sanguíneos/métodos , Transfusión Sanguínea , Francia , Humanos , Plasmaféresis/métodos , Plaquetoferesis/métodos
3.
Leukemia ; 15(10): 1572-81, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11587215

RESUMEN

Platelet transfusion is widely used to prevent bleeding in patients with severe thrombocytopenia. The maximal storage duration of platelet concentrates is usually 5 days, due to the platelet storage lesion that impairs their functions when stored for longer times. Some of the morphological and biochemical changes that characterize this storage lesion are reminiscent of cell death by apoptosis. The present study analyzed whether proteins involved in nucleated cell apoptosis could play a role in the platelet storage lesion. Storage of leukocyte-depleted platelets obtained by apheresis is associated with a late and limited activation of caspases, mainly caspase-3. This event correlates with an increased expression of the pro-apoptotic BH3-only protein Bim in the particulate fraction and a slight and late release of the pro-apoptotic mitochondrial protein Diablo/Smac in the cytosol. Platelets do not express the death receptors Fas, DR4 and DR5 on their plasma membrane, while the expression of the decoy receptor DcR2 increases progressively during platelet storage. Addition of low concentrations of the cryoprotector dimethylsulfoxide accelerates platelet caspase activation during storage, an effect that is partially prevented by the caspase inhibitor z-VAD-fmk. Altogether, DcR2 expression on the plasma membrane is an early event while caspase activation is a late event during platelet storage. These observations suggest that caspases are unlikely to account for the platelet storage lesion. As a consequence, addition of caspase inhibitors may not improve the quality of platelet concentrates stored in standard conditions.


Asunto(s)
Plaquetas/metabolismo , Caspasas/metabolismo , Proteínas de la Membrana , Proteínas Proto-Oncogénicas , Receptores del Factor de Necrosis Tumoral/metabolismo , Apoptosis , Proteínas Reguladoras de la Apoptosis , Proteína 11 Similar a Bcl2 , Plaquetas/enzimología , Conservación de la Sangre , Proteínas Portadoras/metabolismo , Caspasas/efectos de los fármacos , Dimetilsulfóxido/farmacología , Activación Enzimática/efectos de los fármacos , Humanos , Péptidos y Proteínas de Señalización Intracelular , Proteínas Mitocondriales/metabolismo , Transfusión de Plaquetas , Precursores de Proteínas/metabolismo , Manejo de Especímenes , Factores de Tiempo , Receptores Señuelo del Factor de Necrosis Tumoral
5.
Transfus Apher Sci ; 25(1): 67-72, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11791767

RESUMEN

The latest generation of cell separators such as Trima (Gambro), Amicus (Baxter) and AS-TEC 204 (Fresenius), allow the collection of leucocyte-reduced platelet concentrates without secondary filtration. Fresenius has recently developed the COMTEC cell separator whose performance has been evaluated by several teams in France. This new cell separator is an improved version of the Fresenius AS-TEC 204 cell separator, designed to allow more efficient platelet collections. This study reports on the experience of six French teams (from Bordeaux, Clermont-Ferrand, Creteil, Dijon, Lille and Nancy) who obtained 696 leucocyte-reduced plateletpheresis concentrates in the course of collection using the new Fresenius COMTEC cell separator. All healthy volunteer donors fulfilled French selection criteria for platelet apheresis. Donors were eligible if they had suitable venous accesses, if their bodyweight was *50 kg and if their pre-apheresis platelet count was >150 x 10(9) l(-1). Between 4606 and 5229 ml of blood were processed. The mean volume of the platelet concentrates was between 439 and 493 ml (mean 460 +/- 63 ml). The platelet yield was of the order of 5.18 +/- 1.02 x 10(11) with only one platelet concentrate below the norm of 2 x 10(11) platelets (0.91 x 10(11)). No plausible explanation for this was found. The residual leucocyte levels conform to current norms. The platelet concentrates contained less than 1 x 10(6) leucocytes per concentrate (mean 0.233 +/- 0.150 x 10(6) leucocytes) in more than 97% of the components produced with >95% statistical confidence. The efficacy of the cell separator (52.44 +/- 7.35%) is comparable to that of other separators. The Fresenius COMTEC cell separator makes it possible to obtain leucocyte-reduced platelet concentrates which comply with current standards both in terms of platelet content and residual leucocyte level.


Asunto(s)
Glucosa/análogos & derivados , Plaquetoferesis/instrumentación , Adulto , Anticoagulantes/efectos adversos , Donantes de Sangre , Volumen Sanguíneo , Peso Corporal , Ácido Cítrico/efectos adversos , Diseño de Equipo , Femenino , Francia , Glucosa/efectos adversos , Humanos , Depleción Linfocítica/instrumentación , Masculino , Recuento de Plaquetas , Seguridad
6.
Transfus Clin Biol ; 7(5): 485-96, 2000 Oct.
Artículo en Francés | MEDLINE | ID: mdl-11109634

RESUMEN

AIMS: A multicentric study involving 12 centers was made to investigate the results of peripheral stem cell collection carried out between 1996 and 1997 from 655 patients with hemopathic syndromes or malignant tumors, The aim of this investigation was to determine the predictive factors for transplant quality, and to thereby optimize collection procedures. PATIENTS AND METHODS: Information sheets were completed for 1,346 cytapheretic sessions, i.e., 655 grafts. The samples were taken after induction chemotherapy and exposure to hematopoeitic colony-stimulating growth factors (except the LMCs). Each graft was defined as being of good or bad quality depending on the number of CD34+ cells that it contained. Based on the data available in the literature, a workgroup consensus was reached that a level of CD34+ cells +/- 2.10(6)/kg recipient body weight constituted a good transplant criterion. The 2 subgroups (good graft versus lower quality graft) were compared by univariate analysis followed by discriminant multivariate analysis. RESULTS: It was established that a number of parameters were significantly linked to the criterion of collection quality; however, 3 predictive factors emerged from the multivariate analysis--the level of circulating CD34+ cells; the number of cytaphereses; the number of blood volumes treated. CONCLUSION: It was concluded that the level of circulating CD34+ cells seems to be an essential aspect in predicting the quality of the transplant and the number of cytaphereses required to obtain a sufficiently rich collection. Moreover, it also appears that at least 2 blood volumes should be treated to optimize the results.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas/métodos , Adulto , Antígenos CD34/análisis , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Recuento de Células Sanguíneas , Citaféresis/estadística & datos numéricos , Grupos Diagnósticos Relacionados , Francia , Supervivencia de Injerto , Enfermedades Hematológicas/sangre , Enfermedades Hematológicas/terapia , Factores de Crecimiento de Célula Hematopoyética/farmacología , Movilización de Célula Madre Hematopoyética/métodos , Trasplante de Células Madre Hematopoyéticas/estadística & datos numéricos , Humanos , Persona de Mediana Edad , Análisis Multivariante , Neoplasias/sangre , Neoplasias/terapia , Control de Calidad , Estudios Retrospectivos
7.
Fungal Genet Biol ; 26(1): 71-80, 1999 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10072321

RESUMEN

We show that pyruvate decarboxylase (PDC) 8- to 10-nm-diameter filaments, first described in vegetative cells of Neurospora crassa, are ubiquitously present in filamentous fungi. The cellular arrangement of these structures was examined over the entire sexual cycle of the ascomycetes N. crassa, N. tetraesperma, Podospora anserina, and Sordaria macrospora. PDC-filaments were found associated with the cortical microtubule array of asci and ascospores and absent from the vicinity of spindles and spindle pole bodies. Nocodazole-induced depolymerization of the cortical microtubules results in the loss of PDC-filaments. Moreover, a S. macrospora mutant defective in cortical MT distribution shows abnormal PDC organization. Neurospora asci generated on various metabolic conditions, which modify the presence and relative abundance of PDC-filaments in vegetative cells, have identical patterns of subcellular distribution of these structures. A N. crassa mutant (snowflake) that accumulates giant bundles of PDC-filaments during vegetative growth, shows normal distribution of the filaments during ascogenesis. Thus, the regulation conditioning the presence and supramolecular assembly of PDC-filaments in Neurospora differs between vegetative and sexual cells. Taken together, these results suggest that PDC in filamentous fungi may perform two functions, intervening as an enzyme in vegetative metabolism and as a structural protein associated with the cytoskeleton during sexual development.


Asunto(s)
Ascomicetos/enzimología , Microtúbulos/enzimología , Piruvato Descarboxilasa/metabolismo , Actinas/análisis , Ascomicetos/efectos de los fármacos , Ascomicetos/fisiología , Cromatina , Técnica del Anticuerpo Fluorescente Indirecta , Nocodazol/farmacología , Esporas/enzimología , Tubulina (Proteína)/análisis
8.
EMBO J ; 17(5): 1248-58, 1998 Aug 10.
Artículo en Inglés | MEDLINE | ID: mdl-9482722

RESUMEN

The Podospora anserina cro1 gene was identified as a gene required for sexual sporulation. Crosses homozygous for the cro1-1 mutation yield fruiting bodies which produce few asci due to the formation of giant plurinucleate cells instead of dikaryotic cells after fertilization. This defect does not impair karyogamy, but meioses of the resultant polyploid nuclei are most often abortive. Cytological studies suggest that the primary defect of the mutant is its inability to form septa between the daughter nuclei after each mitosis, a step specific for normal dikaryotic cell divisions. The cro1-1 mutant would thus be unable to leave the syncytial vegetative state while abiding by the meiotic programme. cro1-1 also shows defects in ascospore germination and growth rate. GFP-tagging of the CRO1 protein reveals that it is a cytosolic protein mainly expressed at the beginning of the dikaryotic stage and at the time of ascospore maturation. The CRO1 protein exhibits significant similarity to the SHE4 protein, which is required for asymmetric mating-type switching in budding yeast cells. Thus, a gene involved in asymmetric cell divisions in a unicellular organism plays a key role at the transition between the syncytial (vegetative) state and the cellular (sexual) state in a filamentous fungus.


Asunto(s)
Ascomicetos/crecimiento & desarrollo , Ascomicetos/genética , Proteínas Fúngicas/fisiología , Genes Fúngicos/fisiología , Proteínas de Saccharomyces cerevisiae , Secuencia de Aminoácidos , Ascomicetos/citología , Clonación Molecular , Proteínas del Citoesqueleto , Citoesqueleto , Citosol/química , Proteínas Fúngicas/análisis , Proteínas Fúngicas/genética , Meiosis , Datos de Secuencia Molecular , Mutación , Proteínas Recombinantes de Fusión/análisis , Reproducción , Saccharomyces cerevisiae/genética , Análisis de Secuencia de ADN , Homología de Secuencia de Aminoácido , Esporas Fúngicas/crecimiento & desarrollo
10.
Cell Motil Cytoskeleton ; 33(3): 197-207, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-8674139

RESUMEN

A novel isolation of centrosomes is described and it was used to both generate a centrosome-specific monoclonal antibody and to image with high-resolution low-voltage scanning electron microscopy the surface details of the isolated centrosome. At first mitotic prometaphase, sea urchin zygotes are chilled on ice overnight. While most of the microtubules disassemble, the mitotic centrosomes collapse into aggregated masses. These centrosomes have been isolated, and used to generate a monoclonal antibody, designated 4D2, which is reactive with interphase and mitotic centrosomes. 4D2 staining of centrosomes is similar, but not identical, to that of other centrosomal antibodies like Ah6 and 5051. Centrosomal material is detected as a compact sphere after cold treatment; upon recovery the sphere expands and undergoes the shape changes previously described [Mazia et al., 1987: J. Cell Biol. 105:206a] to eventually reorganize a normal mitotic apparatus.


Asunto(s)
Anticuerpos Monoclonales , Centrosoma/inmunología , Centrosoma/ultraestructura , Animales , Frío , Embrión no Mamífero , Femenino , Masculino , Microscopía Electrónica de Rastreo , Microscopía Fluorescente , Mitosis , Erizos de Mar/embriología
11.
Cell ; 81(7): 1043-51, 1995 Jun 30.
Artículo en Inglés | MEDLINE | ID: mdl-7600573

RESUMEN

The car1 gene of the filamentous fungus Podospora anserina was cloned by complementation of a mutant defective for caryogamy (nuclear fusion), a process required for sexual sporulation. This gene encodes a protein that shows similarity to the mammalian PAF1 protein (Zellweger syndrome). Besides sequence similarity, the two proteins share a transmembrane domain and the same type of zinc finger motif. A combination of molecular, physiological, genetical, and ultrastructural approaches gave evidence that the P. anserina car1 protein is actually a peroxisomal protein. This study shows that peroxisomes are required at a specific stage of sexual development, at least in P. anserina, and that a functional homolog of the PAF1 gene is present in a lower eucaryote.


Asunto(s)
Arginasa/genética , Proteínas Fúngicas/genética , Genes Fúngicos , Proteínas de la Membrana/genética , Microcuerpos/ultraestructura , Xylariales/genética , Síndrome de Zellweger/genética , Secuencia de Aminoácidos , Arginasa/biosíntesis , Clonación Molecular , Cósmidos , Proteínas Fúngicas/biosíntesis , Humanos , Proteínas de la Membrana/biosíntesis , Microcuerpos/metabolismo , Microscopía Electrónica , Datos de Secuencia Molecular , Factor 2 de la Biogénesis del Peroxisoma , Plásmidos , Proteínas Recombinantes/biosíntesis , Eliminación de Secuencia , Homología de Secuencia de Aminoácido , Xylariales/crecimiento & desarrollo , Xylariales/ultraestructura
12.
Transfus Clin Biol ; 2(2): 91-9, 1995.
Artículo en Francés | MEDLINE | ID: mdl-7767484

RESUMEN

Surgery, after hematology, is the biggest consumer of homologous platelet concentrates. Platelet transfusion is indicated to prevent or control bleeding associated with deficiencies in platelet number or function. In surgery, general patterns (in function of pre-surgery platelet count) can be adopted in most of the indications for platelets. In emergency situations, and in some particular cases (related to the patient, the type of operation, etc.), the transfusion procedure depends on the team's experience, the results of the available clinical and biological tests, and the drugs. Strict monitoring is required during the transfusion procedure. The efficacy of the transfusion must be controlled 1 h and 24 hours after the transfusion, and a number of factors must be assessed, namely the immunological impact of the transfusion (on red blood cells, leukocytes and platelets) and the occurrence of infectious diseases transmitted via transfusion. In addition, for a possible future transfusion, a strategy must be proposed.


Asunto(s)
Pérdida de Sangre Quirúrgica/prevención & control , Transfusión de Plaquetas/normas , Árboles de Decisión , Humanos , Monitoreo Fisiológico , Transfusión de Plaquetas/efectos adversos
13.
Dev Biol ; 165(1): 257-71, 1994 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-8088443

RESUMEN

In heterothallic filamentous ascomycetes, two nuclei of opposite mating type must recognize one another in a plurinucleate cell to form a pair prior to karyogamy. In pseudohomothallic species, two nuclei of opposite mating type must also pair after meiosis to form a binucleate spore. We have examined the cytoskeletal involvement in nuclear pairings by immunofluorescence and drug disruption, using heterothallic and pseudohomothallic species, as well as species without defined mating type (homothallic). Nuclei of species with defined mating type have spindle pole bodies which react with chromatin stains; those of homothallic species do not. The reactivity is seen only in interphase, not during nuclear divisions; thus, the DNA concerned is nuclear and not organellar. From light and immunofluorescence microscopy, the DNA is located at the nuclear face of the spindle pole body (SPB). We suggest that the DNA-SPB association may be involved in the recognition of self and nonself between nuclei of opposite mating types. Nuclei which cooperate in cell formation during ascus development or sporulation are placed in close proximity by the arrangement of spindles during the division preceding cell formation; after division, each nuclear pair remains linked by intertwined microtubule asters. Nuclear pairs must migrate before binucleate spore formation. Drug disruptions established that actin-myosin interaction was the most important cytoskeletal factor in normal spore production. The ascomycete SPB shows unexpected flexibility in form and location during development. Prior to sporulation the outer plaque shows extensive modification in size and orientation. The modified portion detaches from the nucleus and acts as a cortical microtubule organizing center, while the rest of the spindle pole body remains at the nucleus.


Asunto(s)
Ascomicetos/fisiología , Núcleo Celular/fisiología , Citoesqueleto/fisiología , Huso Acromático/fisiología , Actinas/fisiología , Ascomicetos/crecimiento & desarrollo , Ciclo Celular/fisiología , ADN de Hongos/fisiología , Miosinas/fisiología , Especificidad de la Especie , Esporas Fúngicas
15.
Transfus Sci ; 14(1): 51-5, 1993 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-10148313

RESUMEN

In Besançon, we carried out 40 plateletphereses with the latest model of the Fresenius cell separator AS 104 to check this new system against the new generation of cell separators, according to the following criteria: less than 2x10 6 leukocytes (before filtration) and more than 5x10 11 platelets. The results show that platelet concentrates contained 5.04+/-0.88x10 11 platelets in a total volume of 435+/-113 mL. The mean platelet recovery was 40.95+/-4.86% (from 31.7 to 51.6). The leukocyte content was 2.28+/-5.48x10 6 and the red blood cell contamination was 3.48+/-2.38x10 8. The quality of the platelets was very satisfactory. There was no problem with donor biocompatibility or procedure safety, few adverse donor reactions (0.6%) and good therapeutic efficiency of platelet concentrates.


Asunto(s)
Separación Celular/instrumentación , Plaquetoferesis/instrumentación , Separación Celular/métodos , Seguridad de Equipos , Femenino , Humanos , Recuento de Leucocitos , Masculino , Persona de Mediana Edad , Recuento de Plaquetas , Plaquetoferesis/métodos
16.
Transfusion ; 32(8): 760-3, 1992 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-1412685

RESUMEN

Donated blood is currently screened for hepatitis B surface antigen (HBsAg), antibody to hepatitis B core antigen (anti-HBc), antibody to hepatitis C virus (anti-HCV), and alanine aminotransferase (ALT) levels to prevent posttransfusion hepatitis. A prospective study of 2368 blood donors was carried out in Guadeloupe (French West Indies) with a view to determining the risk factors associated with serologic abnormalities. Blood donors included in the study had to complete a questionnaire. Statistical analysis was performed on the data thus obtained: 571 donations (24%) were positive for at least one of the four analyzed markers. The results were that 3.2 percent were positive for HBsAg, 22 percent for anti-HBc, and 0.8 percent for anti-HCV, and 1.4 percent had ALT > or = 45 IU per L. A good correlation was found between anti-HCV and elevated ALT. Transfusion history and two socioeconomic categories (working class, military personnel) were found to be risk factors. Other risk factors were lifelong residence in Guadeloupe (with risk increasing with the number of years), birthplace and current residence in the southern part of the island, and the existence of gastrointestinal discomfort unrelated to viral hepatitis (odds ratio = 2.98). The results of this study illustrate the difficulty of implementing a preventive policy against posttransfusion hepatitis in a tropical area. The unique epidemiologic situation of Guadeloupe as regards hepatitis B virus has led to more restrictive criteria for the acceptance of blood donors.


Asunto(s)
Alanina Transaminasa/sangre , Donantes de Sangre , Hepatitis B/epidemiología , Hepatitis C/epidemiología , Adolescente , Adulto , Anciano , Femenino , Hepatitis B/sangre , Antígenos de Superficie de la Hepatitis B/sangre , Hepatitis C/sangre , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Factores Socioeconómicos , Indias Occidentales/epidemiología
19.
Rev Fr Gynecol Obstet ; 81(3): 137-42, 1986 Mar.
Artículo en Francés | MEDLINE | ID: mdl-3010432

RESUMEN

The known failures and risks of inducing labour ought to provoke research for novel techniques. Comparison of the results of different methods of established harmlessness must comply with the strict rules found occasionally in the literature. The necessary maturation of the cervical tissue seems an indispensable requirement. Known physiological facts readily call to mind the role played by the granulocytes in collagenolysis. Clinical tests based on them give results identical with other techniques.


Asunto(s)
Cuello del Útero/fisiología , Trabajo de Parto Inducido/métodos , Neutrófilos/fisiología , Bradiquinina/farmacología , Cuello del Útero/efectos de los fármacos , Estrógenos Conjugados (USP)/farmacología , Femenino , Humanos , Hialuronoglucosaminidasa/farmacología , Hidrocortisona/farmacología , Embarazo
20.
Int J Artif Organs ; 8 Suppl 2: 43-8, 1985 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-4055112

RESUMEN

Two new filtration systems (Fenwal CPS 10TM - PS 400 and Organon Teknika Curesis - M82) were evaluated and compared with two centrifugal cell separators (IBM 2997 and Haemonetics V50). 11 patients with auto immune diseases and dermatological diseases underwent 230 consecutive plasma exchanges. For the filtration systems, the average whole blood rate was 50 ml/min and the plasma separation rate was about 21 ml/min for a transmembrane pressure about 70 mmHg. The pre/post percent reduction and sieving coefficient were calculated for some plasma and blood components. A variety of laboratory studies was monitored to assess the efficacy of plasma separators, their biocompatibility and some yields. These results show that the 2 filters appear safe and efficacious but their modules are too simple and do not offer a great security (no transmembrane pressure control or no extracorporeal fluid balance). For a blood banker, IBM 2997 seems more interesting if we take in account its characteristics during plasma exchanges and the possibility which is offered to carry out cytapheresis procedures. But for a thrombopenic patient the filtration systems keep their advantages.


Asunto(s)
Enfermedades Autoinmunes/terapia , Intercambio Plasmático/instrumentación , Enfermedades de la Piel/terapia , Factores de Coagulación Sanguínea/análisis , Estudios de Evaluación como Asunto , Filtración , Humanos , Intercambio Plasmático/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA